Podcasts about CRO

INTELLIGEMSIntelligems brings A/B testing to business decisions beyond copy and design. Test your pricing, shipping charges, free shipping thresholds, offers, SaaS tools, and more by clicking here: https://bit.ly/42DcmFl. Get 20% off the first 3 months with code FARIS20.FERMATCreate funnels the same way you create ads with FERMAT by visiting ⁠⁠https://fermatcommerce.com/af//What do you do when your eCommerce brand stalls—not failing, just stuck?In this tactical deep dive, Andrew walks through a real case study of a 7-figure brand that turned stalled momentum into its most profitable non-holiday month ever. You'll get specific data breakdowns on how changes in spend allocation, campaign strategy (including a massive shift toward Target ROAS), product prioritization, and CRO testing led to a whopping 88% increase in contribution margin—without increasing spend.If you're an operator feeling the pressure to grow but watching margins shrink, this episode is your playbook. Learn how to:- Run leaner without killing momentum- Make Meta's learning phase work for you- Use price testing and retention ads to boost profit per visitor- Think beyond creative volume to win consistently- Reinvest profit into real growth, like product development or new channels//CHAPTER TITLES:00:01:28 - My Brand Experienced Stalled Growth00:05:08 - Less Spend, More Efficient YoY00:06:56 - Spend Down, New Customer Revenue Up00:10:15 - Media Buying Changes00:13:54 - The Limits of Creative Diversity00:18:00 - Product Distribution00:21:17 - Key Takeaways00:28:15 - Spend Smarter Not Harder// SUBSCRIBE TO MY CHANNEL FOR 2X/WEEKLY UPLOADS!//ADMISSIONGet the best media buying training on the Internet + a free coaching call with Common Thread Collective's media buyers when you sign up for ADmission here: ⁠https://www.youradmission.co/andrew-faris-podcast⁠//FOLLOW UP WITH ANDREW X: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://x.com/andrewjfaris ⁠Email: podcast@ajfgrowth.comWork with Andrew: ⁠https://ajfgrowth.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

This podcast episode is designed to offer listeners a discussion about the FDA's evolving stance on animal testing and exploring thoughts on its potential phase-out for monoclonal antibody (mAb) therapies. Hosted by Zac Lloyd and featuring expert insights from Dr. Whitney Helms, Executive Director of Nonclinical Development, Large Molecule Discovery at Eli Lilly and Company, and Dr. Diann Blanset, consultant at Akkeri, Inc., this roundtable-style discussion unpacks the scientific, ethical, and regulatory implications of this paradigm shift. Whether you're deep in the biologics pipeline or navigating the changing CRO landscape, this episode offers valuable perspectives on what the future may hold—and how to prepare for it.

Join Meredith Landry, Managing Editor of Citeline's Custom Content, in conversation with Tom Hickey, Director of Therapeutic Strategy at Novotech, a global full-service clinical CRO dedicated to accelerating the development of advanced and novel therapeutics. In this episode, recorded at the annual BIO conference in Boston, Tom offers a sharp and timely look at the state of RNA therapeutics and shares how innovation in delivery technologies, regulatory strategy, and partnership models is shaping the next generation of RNA-based medicines. With Novotech's deep experience in the space, Tom provides actionable insights for biotech leaders looking to position their RNA programs for long-term success.

Send us a textDr. Marc Salzberg, MD is President, Chief Executive Officer & Chief Medical Officer of Airway Therapeutics ( https://www.airwaytherapeutics.com/ ), a biopharmaceutical company developing a new class of biologics to break the cycle of injury and inflammation for patients with respiratory and inflammatory diseases.Dr. Salzberg has more than 25 years of academic and pharmaceutical experience in the management of drug development and clinical research, including medical management of anti-viral drugs clinical development and market introduction including saquinavir and ganciclovir. He spent several years at Roche's headquarters in Basel, Switzerland as well as its affiliate in Toronto, Canada. As Head of Clinical Cancer Research at the Basel University, he co-founded and managed a clinical research network in Switzerland (CCRC).During his career, Dr. Salzberg has successfully managed the growth and acquisition of two contract research organizations benefitting shareholders. He was a founder and President of Pharma Brains, a European boutique CRO, which has been acquired by Medpace, a US based global CRO, after 10 years of successful growth under his leadership. He then served as Vice President of Medical Affairs at Medpace.Dr. Salzberg earned his Medical Doctorate degree from the University of Basel, Switzerland. His medical training and practice include pediatrics/ neonatology and oncology.#MarcSalzberg #AirwayTherapeutics #HumanSurfactantProteinD #Collectin #PathogenRecognition #RespiratoryDiseases  #InflammatoryResponse #BronchopulmonaryDysplasia #ZelpultideAlfa #Covid #Asthma #COPD #Influenza #RSV #ARDS #AcuteRespiratoryDistressSyndrome #ChronicObstructivePulmonaryDisease #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #ResearchSupport the show

In this special episode, two AI-generated hosts—one male, one female—dive into the world of clinical data management, offering a clear and engaging conversation on what makes data "healthy" in today's clinical trials. Despite being synthetically voiced, everything discussed is grounded in real-world documentation and certified practice. The episode unpacks how systems like CLADE-IS®, developed by the Institute of Biostatistics and Analyses (IBA), meet the highest standards of quality and security—relevant especially for Clinical Trial Units (CTUs) operating within the ECRIN (European Clinical Research Infrastructure Network). You'll hear about: (i) Why CLADE-IS, a validated EDC/CTMS platform, is trusted across ECRIN-certified studies. (ii) The role of IBA as a CRO and data center with ECRIN, ISO, and EHDEN certifications. (iii) Built-in features like risk-based monitoring, anomaly detection via machine learning, and audit trails. (iv) How certification, structured release cycles, and regulatory alignment contribute to dependable and interoperable clinical systems Yes, it's a bit of a product placement—but one with substance. If you're navigating complex clinical data landscapes, this episode may be your shortcut to clarity.

Global SEO is increasingly fragmented across platforms and user behaviors. Sebastien Edgar, founder of SEOSeb and Previsible, explains how search diversification is forcing SEOs beyond their traditional comfort zones. He advocates for an omnichannel approach that leverages content across multiple platforms, urges SEOs to take ownership of the full conversion funnel, and emphasizes the growing importance of CRO alongside traditional search strategy.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Lior is a trailblazing tech visionary and serial entrepreneur, whose latest venture CTOx helps 8 and 9-figure CEOs transition to fractional leadership roles so they can gain better control over their time, money, happiness, and purpose while continuing to drive positive business impact. How can business leaders and tech execs simplify challenges? How best to use AI in business and happiness? How can AI scale your business into predictable growth? How is tech revolutionizing executive leadership? What are the benefits of leveraging tech expertise in a fulfilling, high-income fractional executive practice while maintaining work-life balance? Lior Weinstein Lior is a trailblazing tech visionary and serial entrepreneur, whose latest venture CTOx helps 8 and 9-figure CEOs transition to fractional leadership roles so they can gain better control over their time, money, happiness, and purpose while continuing to drive positive business impact. He has driven digital transformations across mobile, web, and desktop landscapes for 20 years. He founded his first company at just 14 and by his 20s, had built and exited two successful tech companies. Lior has since worked on 30+ mobile apps used by millions of people worldwide and published multiple AI patents. Poplar, Fortunian, Mapp, and Ginipic are just some of the many companies he has founded. While Lior collaborates with elite C-suite leaders to drive value creation and serves as a fractional CTO and CRO for $20-100M companies, some of his most rewarding work has been with nonprofits for causes he is passionate about, such as education and anti-human trafficking. Excellent Executive Coaching Podcast If you have enjoyed this episode, subscribe to our podcast on iTunes. We would love for you to leave a review. The EEC podcasts are sponsored by MKB Excellent Executive Coaching that helps you get from where you are to where you want to be with customized leadership and coaching development programs. MKB Excellent Executive Coaching offers leadership development programs to generate action, learning, and change that is aligned with your authentic self and values. Transform your dreams into reality and invest in yourself by scheduling a discovery session with Dr. Katrina Burrus, MCC to reach your goals. Your host is Dr. Katrina Burrus, MCC, founder and general manager of Excellent Executive Coaching a company that specializes in leadership development.

In this episode, we're joined by Chris Tottman from Notion Capital. Before becoming a VC, Chris co-founded MessageLabs and helped grow it into a $700 million exit, so he's seen the startup journey from both sides of the table.We talk about what really happens when your product-market fit starts to slip—and why it quietly wrecks your entire go-to-market strategy. Sales start missing targets. Marketing can't get traction. Churn creeps up. But most teams keep pushing forward without realizing the core problem is the product just doesn't fit anymore.(00:00) - Introduction (09:55) - Common mistakes in Go-To-Market strategies (19:54) - Identifying a VC case (30:05) - Importance of Product Market Fit (39:38) - Transitioning from VC to PE (50:07) - Next week: pricing changes

In this episode of Coach2Scale, CoachEm CEO and co-founder Colum Lundt joins host Matt Benelli to unpack a critical but often overlooked reality in sales leadership: frontline managers are the linchpin to scalable growth, yet they're routinely undertrained, overwhelmed, and underleveraged. Colum shares firsthand insights on why simply promoting great reps into management roles isn't working and how the right tools, data, and AI-powered systems can transform managers from reactive deal chasers into proactive skill builders.Listeners will walk away with a clearer understanding of how AI should act as a copilot, not a crutch; the compounding impact of consistent developmental coaching over deal coaching; and how to drive real behavior change in reps without adding more to a manager's plate. If you're a CRO thinking about enablement, productivity, and long-term performance, this episode offers a sharp, no-nonsense look at what's broken and what you can do to fix it.Key Takeaway1. Frontline Managers Are the Most Underdeveloped Yet Most Critical Role in SalesManagers get the least training and the most pressure, yet their influence has the highest ROI, up to 7–8x for every dollar invested.2. AI Should Be a Copilot, Not a ReplacementThe future of sales management lies in AI that augments human leadership by handling prep, surfacing insights, and reducing cognitive overload, not replacing empathy and accountability.3. Developmental Coaching Is What Scales, Not Deal CoachingSkills coaching “between the games” has far more long-term value than reactive deal coaching, which often reinforces short-term thinking.4. Manager Span of Control Has ExplodedThe average frontline manager is managing too many reps with too many tools and no time to coach; CoachEm helps them scale themselves without sacrificing quality.5. Change Fatigue and Tech Overload Are Crushing Sales TeamsEspecially in mid-market, reps and managers are drowning in tools and new initiatives without a clear structure or prioritization, which undermines focus and execution.6. AI-Powered Role Play Is a Breakthrough for Enablement at ScaleCoachEm's integration with Hyperbound lets companies simulate real conversations—both for reps and for managers dramatically improving readiness without needing live trainers.7. CoachEm Makes Performance Coaching Measurable and RepeatableThe platform uses CRM, call transcripts, and behavioral data to show exactly what's working and what's not, down to missed calendar invites that slow deal velocity.8. The Best Reps Still Need Coaching, They Need Different CoachingEven top performers benefit from sharpening specific skills; the right system gives managers the data to coach everyone, not just the squeaky wheels.9. Customer Success Is the Next Frontier for Coaching ExecutionAs more CSMs are pulled into revenue roles, CoachEm is expanding to support upsell, cross-sell, and relationship-building motions as rigorously as sales.10. If You Want to Fix Sales Productivity, Start by Fixing the Manager ExperienceSales cultures that prioritize manager development first see better rep retention, stronger pipelines, and more consistent execution across teams.

Can dynamic variables help detecting shaving from operators? Based on a conversation I had last week with Armin Aganovic, CRO of Joelsson Media, I realized that click IDs are more valuable than I realized. That is, operators can't inject fake winning players if you're in control of issuing unique codes within your click IDs.

Dans ce troisième épisode de la série Croître sans s'éteindre, je t'invite à prendre un moment pour réfléchir à ta liberté en tant qu'entrepreneure. Oui, la liberté, c'est essentiel, mais comment rester libre et épanouie quand tu te retrouves à t'accrocher à des stratégies qui ne résonnent pas avec toi ? C'est ce que je vais explorer dans cet épisode.Je partage avec toi mon expérience personnelle de structure et de planification, même en période de chaos personnel. Comment cette structure m'a permis de garder le cap, malgré la pression extérieure. Et surtout, je vais t'expliquer pourquoi ton Human Design est la clé pour sortir du saboteur et naviguer dans ton business sans tomber dans le piège de la comparaison ou de la pression externe.Tu vas découvrir comment :Accepter tes limitations pour ouvrir un champ de possibilités illimitées.Utiliser ton profil Human Design pour comprendre où tu excelles naturellement.Reprendre le contrôle de tes actions, sans te laisser submerger par l'influence des autres.Créer une entreprise qui te correspond, alignée avec ta vision et tes capacités uniques.Je vais aussi te parler de mon propre profil 2-4 et comment il a façonné mon parcours, mes forces et mes faiblesses. Accepter qui tu es et arrêter de te comparer, c'est essentiel pour avancer sereinement et efficacement.

Zach Perret saw a fintech explosion coming—and built the rails before it arrived.On this week's Grit, the Plaid co-founder and CEO retraces his path from building tools for developers to linking the world's largest banks, and how a failed $5.3B acquisition by Visa became a launchpad.He unpacks the pressure of operating in a tightly regulated industry, why rebuilding trust after the deal collapse was harder than expected, and how Plaid is navigating the shift from startup to staple—while staying obsessed with the end user.Links:Connect with ZachXLinkedInConnect with JoubinXLinkedInEmail: grit@kleinerperkins.comLearn more about Kleiner Perkins

Wir kennen sie durch ihre Zusammenarbeit mit Künstlern wie GESTÖRT ABER GEIL, R3HAB oder CRO, ÁSDÍS hat sich längst einen Namen in der elektronischen Musikszene gemacht und begeistert mit ihrer einzigartigen Stimme und starken Hooks. Doch jetzt geht sie ihren ganz eigenen Weg: Mit neuer Solo-Musik zeigt die isländische Sängerin eine persönlichere Seite von sich emotional, ehrlich und tanzbar zugleich. Es gibt also einiges zu besprechen

Send us a textTim Waterton, CRO at HappyOrNot, shares how their iconic smiley face terminals pioneered the micro-feedback approach that has collected over 2 billion pieces of customer feedback across 4,000 brands in 100+ countries. Their in-the-moment data collection method delivers higher response rates and more actionable insights than traditional surveys.• HappyOrNot started with simple four-button terminals and has evolved to include tablet kiosks, digital options, and intelligent signage• Real-time alerts notify staff when customer satisfaction drops, enabling immediate operational intervention rather than just retrospective insights• Micro-feedback approach uses emoji responses followed by maximum 1-2 follow-up questions, making it accessible and easy• Customers frequently provide positive verbatim feedback that identifies and recognizes excellent staff performance• Terminals placed at strategic points (like high-margin specialty counters) help protect revenue while improving experience• The system is designed for easy self-management with pre-configured devices that require minimal setup• AI applications include verbatim analysis, sentiment categorization, and correlation with sales, staffing and foot traffic• Future developments will enable organizations to interrogate connected data sources through conversational AI agents #theproductivityexpertsRegister for the 2025 Productivity ForumFind us in the Top 50 Productivity PodcastsConnect to Simon on LinkedInFollow ReThink on LinkedIn

Cherie R. Cohen is a seasoned media and sports executive currently serving as Global Chief Revenue Officer at X Games. She joined the organization in 2025 as it embarks on evolving into a year‑round international action‑sports league. Prior to X Games, Cherie spent five years as CRO at the World Surf League, where she significantly diversified sponsorships—bringing in brands like Red Bull, Lexus, Neutrogena, Chase, Samsung Electronics, Corona, Apple—and forged partnerships with tourism agencies to grow new revenue streams Earlier in her career, she held key sales and revenue roles at ESPN, NBCUniversal, and Paramount Pictures, managing major events such as Monday Night Football, Super Bowl, the International Olympic Committee – IOC, National Basketball Association (NBA) Finals, and X‑Games .

Jessica Richter is a medtech executive and a board member with MedtechWOMEN. Jessica shares her inspiring journey from B2B sales to becoming a leader in the medtech industry, including overseeing a wide range of vital functions such as clinical trial strategy, regulatory affairs, and market access. Jessica provides insightful advice on overcoming common industry challenges, and underscores the value of quality systems, expert team-building, and fostering a supportive network for women through MedtechWOMEN.   Guest links: https://www.linkedin.com/in/jessica-richter-5aa43517/ | https://medtechwomen.org/ Charity supported: Save the Children Interested in being a guest on the show or have feedback to share? Email us at theleadingdifference@velentium.com.  PRODUCTION CREDITS Host: Lindsey Dinneen Editing: Marketing Wise Producer: Velentium   EPISODE TRANSCRIPT Episode 059 - Jessica Richter  [00:00:00] Lindsey Dinneen: Hi, I'm Lindsey and I'm talking with MedTech industry leaders on how they change lives for a better world. [00:00:09] Diane Bouis: The inventions and technologies are fascinating and so are the people who work with them. [00:00:15] Frank Jaskulke: There was a period of time where I realized, fundamentally, my job was to go hang out with really smart people that are saving lives and then do work that would help them save more lives. [00:00:28] Diane Bouis: I got into the business to save lives and it is incredibly motivating to work with people who are in that same business, saving or improving lives. [00:00:38] Duane Mancini: What better industry than where I get to wake up every day and just save people's lives. [00:00:42] Lindsey Dinneen: These are extraordinary people doing extraordinary work, and this is The Leading Difference. Hello and welcome back to another episode of The Leading Difference podcast. I'm your host, Lindsey, and today I'm excited to introduce you to my guest, Jessica Richter. Jessica is the Executive Vice President and General Manager at Veranex, a global provider of end-to-end solutions that accelerate MedTech innovation through deep expertise and integrated resources. As the leader of Veranex's contract research organization and consulting services business unit, she oversees clinical trial strategy and execution, clinical data services, regulatory affairs, quality and compliance, market access and reimbursement. She also manages operations, client engagement, business development and performance tracking. A seasoned leader in medical devices and diagnostics, Jessica has extensive experience in software as a medical device, surgical innovation, oncology, aesthetics, cardiology and gastroenterology. Her tenure at Medtronic and Becton Dickinson shaped her expertise in commercialization, sales strategy, physician education, patient advocacy, and change management. Beyond her current role, Jessica serves on the boards of medtech, women and UCLA's technology development group. She actively advises startups, accelerators, and universities, including medtech innovator UC Berkeley's Master of Translational Medicine Program, the Mayo Clinic's Executive Steering Committee for the Surgical Innovation Summit, and UCLA BioDesign.   Thank you so much for being here, Jessica. I'm so excited to speak with you. [00:02:15] Jessica Richter: Likewise, Lindsey, thank you so much for having me. [00:02:18] Lindsey Dinneen: Of course. Well, I'd love if you wouldn't mind sharing a little bit about yourself and your background and what led you to medtech. [00:02:26] Jessica Richter: Awesome. Yeah, happy to. So, I was born and raised in California. I am the youngest of three girls and my entire family is really in the healthcare delivery field. So both my grandfathers were surgeons. My mother is a nurse. Both my sisters are clinical psychologists. And so when I went to school, I had aspirations at one point to get into medicine, and then through a really challenging organic chemistry class, kind of started to realize that maybe the practice of medicine wasn't where I belonged. And so I initially graduated from Berkeley, had my sights set on potentially doing something in communications, and started off in business to business sales in the telecom industry. So as far from medtech as maybe one could think. Had some experience with software, this is when Blackberries were a thing, if you remember those. And then a friend of mine was a recruiter and reached out and said, "Hey, I, I know that you're into medical and into medicine, and that was something you were interested in. Have you ever considered a career in medical device sales?" And frankly I didn't even know that that existed. I mean, this was 20 years ago, so this was before, you know, internet and all of those things existed, obviously, but it wasn't as pervasive as it is now. And so I wasn't even aware that these jobs existed. The fact that you could be working on the delivery of care but not be a healthcare provider was an eyeopening moment. And so I got in and started actually working at a surgical company called Deval. It's part of CR Bard, which is now part of Becton Dickinson, and I cut my teeth in medical device sales. And then I went on to work in a commercial role within other companies Given Imaging, Covidian, Medtronic. I ascended to sales leadership, working with key opinion leaders, working on the patient advocacy side. And then about eight years ago, I had the opportunity through an organization that we'll talk a little bit more about, called MedtechWOMEN, that I was involved in to learn about a consultancy that was looking for a head of business development marketing. It was a small group called Experian Group. I joined them and then within nine months was promoted to Chief Operating Officer, which was a position that I absolutely loved because we were working on the pre-commercial side of things and regulatory quality systems, clinical trials. And I had always had experience in the post commercial side. So eyes open to what happens, everything leading up to commercial. And I got a masterclass from my colleagues there, learning so much about what happens again, pre-commercial. But then one of the other things that came out very quickly is I've always been someone who loves operational efficiency. And I know that's not sexy or cool, but I just like seeing something that isn't working optimally and get it working optimally is something that brings joy. So I had the opportunity to do that within Experian Group, and then really help the organization, which was already very successful, go from a very successful kind of local consultancy to a much larger, broader group with a broader footprint, more global client base. And then we were acquired by the firm that I currently work with called Veranex, and that really exploded capabilities of what was a 50% consultancy to now over a thousand people with a much broader global reach in the US, in Europe, and in India. [00:05:36] Lindsey Dinneen: Wow. That is incredible. Well, first of all, thank you for sharing your story and your background and all the amazing things that led you to where you are right now. That's incredible. So many questions, in a good way. But let's dive in a little bit about, yeah, so, so tell us a little bit more about your role right now, and what are you excited about as this consultancy continues to grow and new opportunities arise. What's on the future for you? [00:06:02] Jessica Richter: So now I lead one of three business units here at Veranex. So I lead our CRO and Consulting Services Business Unit, and that encompasses regulatory, quality, and clinical, as well as commercial strategy, market access reimbursement, things like coding, coverage, payment. So we help mid-size, early stage, and some of the largest strategic medtech companies, as well as some biopharma as well with companion diagnostics, navigate sometimes the tumultuous waters needed to bring a device from inception all the way through to commercialization. Veranex also has two other business units in preclinical as well as extensive design, development and engineering. So there's leaders in each of those capacities. And what we do on CRO and consulting services is really consultative. So we work with clients to develop strategies in all of these areas, and then we roll up our sleeves and work alongside them to make sure that those strategies are actually executable, so to help them along the way. And some of our clients have teams, so it's strategic and we're advisors. Other clients, if they're early, early, may not have extensive expertise or the ability to build out teams in that way. So we go in, or our team goes in, and really provides them that support along the entire continuum. It's interesting, just today, we have a client we've been working with for two years. They're in Switzerland, but they've been working with our US and global team. They just got news from FDA that they obtained FDA clearance. And I'll tell you, I think our team is as excited as theirs because, when you're in a company, it's all that you're living, breathing, doing. When you're consulting, you're a little bit at an arm's length. So when our clients achieve their results, and it's their work, but in concert with ours, the feeling of accomplishment really is just, it's one of those that's explosive. So we've celebrated that. We ring a bell. We'll share a lot, we'll do some marketing around it with this client. But it's really fun. That's the part that really drives not just me, but members of our team as to "How can we help more companies get more products to patients?" [00:07:58] Lindsey Dinneen: I love that. First of all, congratulations, that's exciting, and I'm thrilled for your clients and for you guys because it matters so much and what a great milestone. So that's wonderful. But yeah, so I'm curious, you've seen a lot of different sides to medtech and to the business side of things, and I'm curious what are some potential stumbling blocks that you have seen that companies, especially when they're perhaps a little bit younger or earlier on in the process, what are maybe one or two stumbling blocks that you see that you think, "You know what, hey, if we put a little bit of thought into this, we can overcome this very easily, but we need to be thinking about this from the start." [00:08:36] Jessica Richter: Okay. There's two things. One of them is gonna be a shameless plug, but I swear it's true, and that's quality. I think companies don't focus enough on quality systems 'cause it's just not the fun or sexy thing, but it's literally where we see companies struggle because they think about it too late. They do just in time. They think an EQMS is the answer, and it's not the only answer, it's a component. So quality would be the short answer. The longer answer is people. So what we see is oftentimes, people, especially in a cost constrained environment, which we are today, where fundraising is tough, people do need to be financially astute as far as what they're spending and how they're spending it. But sometimes you get more by spending a little bit more to get the right advice. So for example, if somebody is expert in engineering or expert in regulatory, excellent. Know where your expertise is not, and then supplement. So either hire a consultant or bring on an employee or have a member of your board that can advise them that way. More often than not, we see people trying to just kind of figure it out as they go, which isn't a bad strategy, but there are critical decisions and inflection points along the way. For example, if you're developing a clinical trial, thinking only about your regulatory strategy and not about your commercial goals or the claims you're going to make, you are gonna have to ultimately spend twice as much when you have to do secondary studies that you could have avoided by including that in endpoints. So there's little things like that along the way where if you don't know what you don't know, it's really difficult to see those hurdles. It's helpful to bring in people, even in an advisory capacity, to help you say, "Okay, these are the hurdles that you're gonna face." You're gonna have new hurdles that maybe that you won't know or people won't know, but it's really making sure that you surround yourself with experts in those key areas. [00:10:25] Lindsey Dinneen: Mm. That's great advice. Experts in those key areas. Well, speaking to the advisory point, I'd actually love to talk about your involvement with MedtechWOMEN, and tell us a little bit about that organization and how it serves women in this industry. [00:10:39] Jessica Richter: Absolutely. Thank you for asking. It's something that I could literally talk about for this entire podcast. So, I alluded to it earlier, but MedtechWOMEN, I got, and I say "roped in" lovingly, but I was introduced to this organization, gosh, maybe a decade ago now when I was at Covidian and then Medtronic, and a mentor of mine, Amy Belt Raimundo, was one of the founders of MedtechWOMEN. And she had mentioned to me, because there weren't a lot of female leaders within that section of my business at the time, so I was paired with her and it feels like kismet because she was this spark of like, this is what badass female leadership looks like. She knew her stuff, she was really focused on the issues. She made time and said yes anytime I had a question or wanted to meet. Our conversations were really meaningful and actionable. Sometimes we just talked as friends. It wasn't always so agenda based, but she introduced me to MedtechWOMEN and shared with me that there's this organization. It's all volunteers. It's kind of membership based and it's literally women getting together talking about the issues in our industry. And it wasn't as focused on things like work-life balance, which quite frankly is a challenge, no matter what your gender is. There are great forums for talking about work-life balance and how you prioritize your health and your mental wellbeing, and that is really, really important. But some of the events that I had gone to as far as women in leadership or women in medtech were really focused on those things and that wasn't what I wanted to talk about. I wanted to see incredible pioneers or trailblazers in our industry talking about the things that mattered in industry and sharing their perspectives. And that's exactly really the thesis of MedtechWOMEN. And so it was an organization founded over a decade ago. It started really as just an annual event, this MedtechVISION event, where we brought women together on a podium talking about the issues impacting healthcare today. It evolved. So after a couple of years and a couple of different topics, what we started to see is that there was a real thirst in the community that we had beyond just that individual or that one time a year we got together for the event. And so we developed a kind of MedtechWOMEN 2.0. We brought on an Executive Director. And we essentially launched a much, much grander vision of what MedtechWOMEN was. So it included membership. It included mentorship, so formal pairings. We created a board of directory, kind of a pathway to get to more women on boards. We also have local events, networking events, virtual events in partnership with our sister organizations like MedTech Color and Diversity by Doing. And then of course we still have our annual event. And then just this past month we actually brought on a new executive director. Her name is Yvonne Bokelman. She is a longtime industry veteran, tremendous leader in medtech, and someone who's really passionate about the organization, the mission, the vision. So we're excited to see what she will do in her role here. [00:13:38] Lindsey Dinneen: Yeah. That's incredible. Thank you so much for sharing a little bit about the organization and its history and who it is serving, and it really resonated because I agree with you that there's wonderful platforms for being able to talk about some of the. Some of the topics that tend to come up quite a bit for women, especially women leaders, and I love the fact that you are fully acknowledging that those things are great as well, but that your focus is a little bit different. And so I'm curious, what are some interesting stories or things that have happened maybe unexpectedly from this network of incredible women supporting each other, learning from each other. Can you share a little bit that? [00:14:17] Jessica Richter: Oh yeah, absolutely. And I'll tell you, many of us that have been members for a long period of time will attest to the fact that job opportunities come via this network, learning opportunities, sales and business opportunities. I mean, we network in the same way that we would in any other conference or any other meeting, but deals certainly have gotten done within and at MedtechWOMEN and MedtechVISION events. But most importantly, and one of the things that I always tout, is that MedtechWOMEN is a sisterhood that will take that call. And what I mean by that is if you have a question, if you need to phone a friend-- going back to what we were talking about earlier of that network of you don't know what you don't know, but somebody probably does-- within MedtechWOMEN, someone definitely does. And so what we encourage our members and our mentors and anyone that's a part of the organization to do is reach forward and reach back. And so when I say take that call, if someone calls-- and I just had literally three conversations in the last three weeks-- with more junior people looking for career advice or wanting to have a question about regulatory or their thinking about a decision point in their job, and what should they do? I always take that call and, you know, we're all busy. We all have things to do, but that 30 minute conversation can have a really big difference. And I know for me, likewise, when I have a question, when I'm coming up against something where it's helpful to have a thought partner, sometimes you want that outside of your own company, or outside of your boss, or outside of your team. And so the MedtechWOMEN Network is incredibly powerful and very supportive. And in my experience, and I've tried it both ways, we will always take that call. [00:15:53] Lindsey Dinneen: Oh wow. That's incredible. So, okay, so mentorship and leadership is obviously a key component of your life, something that you're passionate about. From your own experience as a woman in this industry, are there any things that come to mind that you would say, just pieces of advice-- let's say for other women who might be younger in their career and they're looking to grow, they're looking to become leaders, they're looking to become maybe thought leaders, or own their own company, things like that-- what are some things that you might suggest to them from your own experience would be helpful? [00:16:27] Jessica Richter: Oh yeah. It's, it's a great question, Lindsey, because there's a lot of things. I wish we could just mind share. First and foremost, I would tell women to go for it. I think sometimes we self-sabotage or hold ourselves back if we don't have all of the information or feel like we're a hundred percent qualified. And there's been tons of studies that demonstrate that. So first and foremost, go for it. I had this conversation with one of my mentees who was taking on a new role and I said, "It's okay that you're feeling this way or that way. Do it and do it scared." Like it's okay to not feel like you have all of the confidence, right? And it doesn't mean fake it till you make it, although there's a little bit of that too. But I would say don't let fear hold you back. So that would be the first piece of it. The other piece of it is make sure that you have, really, your own board, meaning advocates, mentors, coaches, thought partners, people that you can reach out to and rely upon. And that has to work both ways. I will tell you, I have learned as much from mentees as I have learned from mentors. And so recognizing that knowledge is shared both ways, no matter what your seniority is. For people that are junior, they have their on the pulse of things that I'm not as privy to, and sometimes I feel, feel that even more strongly. Likewise for people that have been in this industry 40, 50 years, they have institutional knowledge that I only wish that I had. And so, being at this midpoint in my career, I'm sandwiched between both and really appreciate, so I would implore people that are hoping and wanting to pursue leadership, go for it. [00:18:00] Lindsey Dinneen: Yeah. Thank you for that. I, I love that advice. I really appreciate it. So, you have had such an interesting career and going from communication and sales, and then to this new role and Chief Operating Officer, all these cool things. For your own leadership style, what would you say are maybe one or two key things that you have found to be really helpful for you as a leader in the industry in the way that you approach the people that you lead? [00:18:30] Jessica Richter: Another great question, Lindsey. So I would say, well --first maybe I'll share some lessons learned 'cause I've made a ton of mistakes. So I think one of the things that I didn't appreciate early on as a leader that I definitely appreciate now, is that we all have our own lens, our view with which we take on and see the world, and that's the view in which, you know. And so as a leader, initially, my thought was, "Well, everyone kind of sees and feels it this way with their own flavor." That is not true. Everyone has their own view and that's really shaped by their family, their background, their culture, lots of different aspects. And so I think for me, some advice as a leader would be, be humble, take the time to really seek to understand, and then, even if you are heightening your communication, multiply that times three or four and then you're probably scratching the surface, 'cause people need to hear things different ways, multiple times. And it doesn't mean you need to micromanage or drill things down, but when you're leading an organization and bringing people along on a change, especially, it is important that people understand the why, the who, the what, the how come, and that they hear that re repeatedly so that they can understand it, they can buy into it, and that you're creating an environment to make sure that their questions are addressed. So, lesson learned kind of recommendation on the leadership piece. I think the other just piece of advice is that sometimes people aspire to leadership because they think it's glamorous or there's gonna be a lot of money there, or it looks like the leader doesn't have to do that much work, they're just delegating. What I would say is leadership is not glamorous. It's often thankless. It's super hard. I work tons of hours and I love the team that I work with, and so for me the why is that. But if you are not loving that, don't do that. There's plenty of opportunities that you can contribute meaningfully as an individual contributor or a principal or a subject matter expert, and that's great too. So know that if you want to lead people and be involved on that side of leadership, I welcome it. I think it's fantastic. I think there's a lot of people that get into it with a misconception of what it will look like. And I'll tell you it's worthwhile, but it's hard. [00:20:43] Lindsey Dinneen: Yeah, absolutely. Yeah, when you were talking about that it, the glamor side of things, I just remember so vividly and I, I joke about it because I think it's funny-- but very quickly, I used to own my own dance studio and I built that from the ground up. And people would say things to me like, "Oh my goodness. What you're doing, you're living your dream. That's amazing! Oh my gosh, how cool is that?" And inside, I'm like, "Ha, yeah, I mean, I spent the first two hours as the janitor this morning, and then the next two hours as the CEO. And then, you know..." And it's funny, but it's true, you wear a lot of hats as a leader and sometimes your job is literally getting down into the nitty gritty and cleaning up, and that's fine too. So I love that. [00:21:24] Jessica Richter: My quip is always from the janitor to the GM, like, "What needs to get done? There's no task too big or too small." And ultimately, I think that what you described in yourself, and I love that, is servant leadership, right? Like for me, I've always responded well, when a leader isn't above any task and doesn't ask for something that they themselves would not be willing or aren't willing to do along with their team member. And so again, that's, that's not the definition of leadership, but in my eyes, that's a definition of leadership that really resonates with me. [00:21:55] Lindsey Dinneen: Mm-hmm. I agree. Yeah. Well, speaking of stories and those kinds of fun things too, are there any that stand out to you, perhaps along your career or with MedtechWOMEN, or anything really, that just affirm to you that, "Hey, I am in the right industry at the right time, doing what I should be doing?" [00:22:14] Jessica Richter: Oh yes. So there's a couple of different specific examples. So firstly, one of the things that has happened as of late, and I feel like-- not to get too woo or California on you-- but these synchronicities where you'll be thinking about something or remembering something, and suddenly a project and people come together around it-- and again, I think that's part of the power of the network. But there was a friend of mine that I had run into at a conference, we were talking about a specific aspect of their business that was really needing some, some development, and it turned out that after that conversation, literally not a week later, I got a call from a prospective client that was interested in working in this specific space. We were able to connect them with this person that was in need of that exact thing. And it was with software and with AI and so a partnership was forged and now they are literally about to embark in this really explosive and announcement will be forthcoming about it. But there's so many examples of little nuances and synchronicities like that, that again, happen because of staying open, staying curious, that powerful network right place, right time. But I also think it's the magic of our industry. It's really small. People sometimes fail to appreciate because you have these large organizations that are hundreds of thousands of people, but the leaders within the organization are fairly connected and tight. It's really an interconnected ecosystem. So that's just kind of one broad example. There's also other really small examples of the power, I think, of MedtechWOMEN in just how it ignites and how it brings people together, especially across senior and junior roles. So when we do our networking events, we try to do them regionally, just to try to bring different people together. And you can have like the CEO of sometimes a large organization, like Lisa Earnhardt from Abbott is a member and an active participant. She often will come to events talking to someone who's their very first year in medtech. And when you see these examples of sponsors of ours really showing up and demonstrating a commitment to giving back, and you see these people that are junior that may not even know the seniority of the leader that they're speaking to, recognizing that we're all people at the end of the day, trying to really ideally propel healthcare and help patients in their journeys to health and wellness. And so when you see examples of those sparks and those little ignites, it reinforces why we're here, what it is we're doing, and really the power of the organization. [00:24:41] Lindsey Dinneen: Yeah! Well, I think that the more times that you get to see those connection points, and those synergies or whatever we wanna call them, I think that that does impact us in a way that goes, "Yeah, the work that I do matters and it's impacting people's lives and maybe in very different ways." So some of it is, yeah, that end user and that patient, and oh my goodness, what this device can do for them and their quality of life. And sometimes it's the person behind the invention and what does that journey look like for them personally and the impact on their own family and their life. So I love hearing about those connection points. [00:25:16] Jessica Richter: Well, and that's the joy of working also with, I mean, large strategics for sure, but the startup companies, oftentimes it's a physician and engineer. The physician is seeing the unmet need because of the patients coming into their clinic. They're feeling hopeless 'cause they can't address it, but also empowered because they know what to do. So those are the really fun, kind of feel good projects, especially because there is no one better equipped than a clinician, right, to say, "Okay, here's the gap." Engineers can help to design and develop, but oftentimes that's where the teams are sort of left in the lurch to say, "Okay, what do we do from here?" And so it is incredibly powerful to enable these innovators, no matter what their backgrounds are along that journey. And it's not a quick one as you know, being on the manufacturing side. It's not something that's quick or easy. It's not something that is a high success rate. And when it works, there is no better feeling. When you commercialize a device or when you get it through the FDA, that's just the start. When it's actually used in patients and you start to hear those patient advocates and those stories, and you expand indications and are able to help more patients, that's the thing that makes it worthwhile. And when the going gets tough, 'cause it does that, those are the stories, right, that really inspire us to continue. [00:26:33] Lindsey Dinneen: Yes, absolutely. Amen to that. So, okay, so I have so many thoughts swirling around, but I do want to pivot the conversation a little bit just for fun. So imagine that you were to be offered a million dollars to teach a masterclass on anything you want. It can be within your industry, but it doesn't have to be. What would you choose to teach? [00:26:53] Jessica Richter: Oh, I love this question. I'll try to make it not about our industry 'cause it's something I've been working on a lot lately, and it's a testament to patience, which is something that I think we could all use more of, but I could definitely use more of. So we rescued a dog in Covid. She's a Doberman pit mix. Her name is Poppy and she's delightful. And she was severely neglected. So when we got her, we knew she was really shut down and that we would have to do work to bring her out of her shell. My husband and I don't have kids. We have a quiet home. I knew that we could take that on. And so while I won't say I am the expert, what I have done in the four years we've now had her, is extensively worked with her on the, what I would call the "Art of the Dog Walk." So we have learned how to really master exercise, training, and discipline as a way to show affection, 'cause for a dog that shut down like that, that's really what she needed to thrive. It was humbling and very educational for me. I've always been a huge animal lover. I used to volunteer when I had a lot more time with an animal rescue. And so I was able to parlay that and work with a trainer really on honing those skills so that Poppy could not just be social in the world, but be less shut down. So it would be so fun to share a masterclass on that 'cause I had so many reflections and learnings on patience. The art of going slow, the art of taking in the world, of just slowing that down, not being on my phone, right, being really present with her. And I sort of joke with my husband, I feel like now when I walk her-- I dunno if you've seen the movie "Avatar"-- but like we connect our avatars and we like go on into this world, and it's meditative. It's our morning practice and it's something that for me has been incredibly rewarding, and challenging, and a huge learning experience that, that I would love to share. [00:28:50] Lindsey Dinneen: Oh, that's wonderful. Oh my goodness. Yes. I am a huge dog lover, so anytime someone's telling me about their dog, it's just instant happiness. [00:28:59] Jessica Richter: Likewise. And for my, my favorite thing that it will always bring a smile to my face is the unlikely animal friends, like if you see like a squirrel a dog or a kookaburra or something, you're like, "Ahh!" [00:29:10] Lindsey Dinneen: It's so cute. It's precious. Yes. I love it. And to me it reinforces, "Hey, we can actually all get along if we try." I mean, I know it's a little different in the animal kingdom, but still, I still love that. Oh my goodness. Great. Well then, how do you wish to be remembered after you leave this world? [00:29:32] Jessica Richter: You know, legacy is something, that I think is important. It's funny, I've been working with my niece on her college essays and college admittance, and reflecting back to my views when I was 18 versus my views today in the world now. And even speaking to my mom about legacy, 'cause it's something, you know, she's approaching her eighties that she thinks more and more about. So it's conversations that we have a lot. I really would love to be remembered as an enabler, as someone who really enables those around me to be successful, to achieve more, to obtain what they want right to, to drive forward. I love being around creative people and innovators and people with really expansive imaginations, and I think my superpower is kind of capturing and enabling those things. So it would be great to be able to enable more people around me. And that's true with patients and healthcare and the clients that we support as well. You know, one of the things that has always been pointed out to me-- and again, my grandfather was a huge proponent of this-- is when things aren't going well in the world, you can focus on what's going wrong or you can look for the helpers. And so, as a surgeon, he was one of those helpers. And so I think he ingrained that in me very early on. And so I'd love to be remembered as someone who is a helpful enabler. [00:30:51] Lindsey Dinneen: Hmm. Yes. That's a beautiful legacy. I love that. [00:30:54] Jessica Richter: I am curious, Lindsey, I know this is like, you're the, you're the interviewer, but how would you like to be remembered? [00:31:02] Lindsey Dinneen: Oh, thank you for asking. First time! You know, there are so many things, so many things that I love doing for other people. But I really actually resonated with your idea of enabling. And I would say mine is very similar. And that is that I love helping people achieve their dreams. And that can look like lots of different things to lots of different people. So it's when I'm working with a company, it always started with one person's idea, right? All these big companies started off as this tiny little one person's idea that became something. And I think just helping that, those sparks, especially when maybe they're eager, but they're not quite ready. They're scared, they're nervous, they're whatever, and helping them see a clear path to achieving those dreams and goals is one of my favorite things. And whether that's just a personal, I wanna run a marathon, I don't even how to know how to get started, or whether it's, I have this great idea for a book, but I am concerned about, like, "Nobody will read it, no one will care." Well, that's not the point. Let's start somewhere. And so I think for me, it's about empowering people to live the life that they want to live and hope that they can live. That's what I would love to be remembered for. [00:32:16] Jessica Richter: Well, that's beautiful. I hope that via this and the other things that you're doing, it seems like you're already on that track. [00:32:22] Lindsey Dinneen: Well, thank you. I appreciate that. I really appreciate you asking me too. Thank you. Well, and then final question, and you've sort of perhaps alluded to this-- I'll see if it's different than your first time-- what is one thing that makes you smile every time you see or think about it? [00:32:37] Jessica Richter: Oh, well, definitely the unlikely animal pairings for sure. [00:32:41] Lindsey Dinneen: Yes. [00:32:42] Jessica Richter: Anytime with family. Family is super important to me. So anytime I can spend time with our family, that is for me, a smile doesn't go off of my face. And also kind of what you said, celebrating other people's wins. And I celebrate my own as well-- I think it's important that we do that-- but there is nothing like, it's a grin, like when someone on our team has an accomplishment, the grin is twice as big, right? Because you just, to see that reflected, that success, that attainment, that win reflected for the people that you work alongside, that brings a smile to my face every time. [00:33:20] Lindsey Dinneen: Yeah, nothing quite like it, and it's so powerful. Yeah, huh. Oh my goodness. Well, this has been an amazing conversation. I don't really want it to end, but I know we have other things we have to get to today, so I just wanna take some time to say thank you so very much for being here with me, Jessica. Thank you for sharing all about your incredible career so far and all the exciting things that are to come, and speaking to MedtechWOMEN and that incredible organization. So I'm really excited for our listeners who might not have been familiar with it to go check it out, lots of opportunity there. And gosh, I just wish you the most continued success as you work to change lives for a better world. [00:34:01] Jessica Richter: Thank you, Lindsey, for hosting and I would encourage anybody who's unfamiliar with MedtechWOMEN, if you're new to industry or if you've been here a while, there is a place for you within MedtechWOMEN. Membership is super low cost. It's $150 for standard membership a year, $75 for junior members. You can follow us on LinkedIn, but highly, highly encourage everyone to join the network. And thank you for the opportunity to share a little bit more about MedtechWOMEN today. [00:34:26] Lindsey Dinneen: Of course. We are so honored to be making a donation on your behalf as a thank you for your time today to Save the Children, which works to end the cycle of poverty by ensuring communities have the resources to provide children with a healthy, educational, and safe environment. So thank you so much for choosing that charity to support. Thank you also to our listeners for tuning in, and if you're feeling as inspired as I am right now, I'd love it if you share this episode with a colleague or two, and we'll catch you next time. [00:34:57] Jessica Richter: Thanks, Lindsey. [00:34:59] Ben Trombold: The Leading Difference is brought to you by Velentium. Velentium is a full-service CDMO with 100% in-house capability to design, develop, and manufacture medical devices from class two wearables to class three active implantable medical devices. Velentium specializes in active implantables, leads, programmers, and accessories across a wide range of indications, such as neuromodulation, deep brain stimulation, cardiac management, and diabetes management. Velentium's core competencies include electrical, firmware, and mechanical design, mobile apps, embedded cybersecurity, human factors and usability, automated test systems, systems engineering, and contract manufacturing. Velentium works with clients worldwide, from startups seeking funding to established Fortune 100 companies. Visit velentium.com to explore your next step in medical device development.

Lee shares the sales effectiveness habits that separate top performers from the rest: Why training alone doesn't work—and what coaching really looks like How to develop curiosity and authenticity as sales superpowers What deliberate practice means (and why most teams skip it)How sales leaders can drive better prep, follow-through, and customer trust Why sales enablement needs a seat at the strategic planning table Whether you're a CRO, VP of Sales, or sales enablement leader, this episode will help you refocus your team on what actually drives pipeline momentum: authentic preparation, emotional intelligence, and trusted conversations—not just activity volume. Flat or slowing revenue? Let's fix that—fast.Revenue Boost: A Marketing Podcast delivers the proven plays, sharp insights, and “steal-this-today” tactics that high-growth teams swear by.Follow / Subscribe on Apple, Spotify, and YouTubeTap ⭐⭐⭐⭐⭐ if the insights move your metrics—every rating fuels more game-changing episodes

SEO Optimizing Websites: SEO, AI, for High Market Authority with SEO Expert, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Favour Obasi-ike, MBA, MSFrom this episode, Favour had audio Marketing Clubhouse audio roundtable session, where we discuss crucial aspects of Search Engine Optimization (SEO) for websites, particularly focusing on new and established online presences. He emphasized the need for a strong web presence in today's digital landscape, despite the rise of AI tools like ChatGPT, as these AI systems often pull information from well-optimized websites.Key topics include understanding Google's new "MUVERA" algorithm (Multi-Vector Retrieval Algorithm), the importance of technical SEO elements like H1 tags and schema markup, and the value of local SEO strategies. The discussion also highlights the utility of screen recording tools like Loom and Vimeo for business communication and sales, and the significance of conversion rate optimization (CRO) to ensure website effectiveness.FAQs on New Website SEO Optimization for Businesses1. Why is having a website crucial for a business, even in the age of AI and platforms like ChatGPT?In today's digital landscape, a website remains an indispensable asset for any business. While AI tools like ChatGPT are powerful for information retrieval, they primarily draw content from existing websites. If your business doesn't have an online presence that these AI models can access, it becomes challenging to be discovered and gain long-term visibility. A website serves as your digital storefront, your authoritative profile, and a valuable asset that allows AI to pick up on your offerings, ensuring your brand is seen, heard, and remembered.2. What is Google MUVERA, and how does it change the way Google's algorithm functions?Google MUVERA, which stands for Multi-vector Retrieval Algorithm, is a new algorithm launched by Google. It signifies a shift in how Google processes information. Traditionally, Google acted like a library, providing direct results based on keywords. With MUVERA, Google's algorithm goes beyond simple keyword matching.3. What is the "ABC of SEO" and why are all three components essential for a website's visibility?The "ABC of SEO" outlines three fundamental aspects for a website's online visibility:A - Crawling: This refers to whether search engine bots (like Googlebot, Bingbot, or AI bots) can access and read your website's pages. If your pages cannot be crawled, they cannot be discovered by search engines.B - Indexing: This is the process where bots analyze your content and decide whether to include it in their search results listings. For content to be indexed, it must meet quality standards and be relevant to potential searches. It's like a library deciding if a book is valuable enough to be put on a shelf for readers.C - Serving (Search Results): This is the final stage where your content is presented to users in search results. This involves not only basic links but also rich snippets, FAQs, and other optimized elements.Looking for Business Inquires with ⁠⁠⁠SEO Services⁠⁠⁠ > Book A CallMore Resources:>> ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Join our exclusive SEO Marketing community⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠>> ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Latest blogs on SEO optimization and Online Marketing⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠>> ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Book your Complimentary SEO Discovery Call⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠>> ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Book Paid Marketing Consultation Call⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠>> ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Subscribe to We Don't PLAY Podcast⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠>> ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Start Your Email Marketing 14-Day Trial with Flodesk⁠⁠⁠Brands We Love and Support⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Loving Me Beauty | Buy Vegan-based Luxury Products⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Zetvaa | Buy Premium Human Hair Extensions Online

Buckle up for a marketing revolution!

Sarah and Nate break down a super strange, but very psychology-based CRO test, we chat about how bundles have completely changed Original Grain's whole business strategy, and contemplate the meaning of brand. All this and more, on this episode of Brain Driven Brands.   JOIN The TETHER Community- https://www.skool.com/tether-lab/about   CoHost: Nate Lagos Twitter: https://x.com/natelagos LinkedIn: https://www.linkedin.com/in/natelagos/ Tactical and Practical Podcast: https://podcasts.apple.com/us/podcast/tactical-practical/id1752915534   Learn more at: https://www.tetherinsights.io/ Twitter: https://x.com/SarahLevinger Linkedin: https://www.linkedin.com/in/sarahlevinger/  Instagram: https://www.instagram.com/sarah.levinger/ Watch me on YouTube: https://www.youtube.com/channel/UCKwfjt_7PU5N_2fTfHemXXg   Thanks to Cytrus for the theme song, “Sky High” You can follow and find them on Spotify:https://open.spotify.com/track/1oKGDsxjRdQlf2xHLZsiSJ?si=8fbd275dbbb54cbf  

In this episode of CRO Spotlight, Warren Zenna sits down with Bobby Morrison, Chief Revenue Officer at Shopify, to explore how the CRO role has evolved beyond traditional sales leadership. Bobby shares his approach to unifying marketing, sales, customer success, and support under a single revenue organization focused on the complete customer journey rather than siloed handoffs.Bobby reveals his philosophy of building revenue flywheels through aligned incentives and systems-first thinking, explaining how he restructured Shopify's go-to-market approach to eliminate friction. He discusses the importance of creating pods that bring together account executives, solution engineers, and customer success managers with shared objectives and territories to deliver better customer outcomes.The conversation shifts to how AI is transforming revenue operations, with Bobby predicting that traditional CRMs will be replaced by AI-enabled systems within months. He emphasizes that tomorrow's successful CROs must become more technically proficient, understanding data structures and AI capabilities to build competitive advantages through technology while maintaining the human relationships that drive trust.Warren and Bobby conclude by discussing the future of customer engagement, with Bobby sharing his belief that despite automation, human interaction remains essential in building trust. He emphasizes Shopify's commitment to helping customers navigate uncertain times through an anti-fragile platform that enables businesses to adapt quickly to changing market conditions.

"Bringing in a CRO too early is the death of any business. It's like bringing in Lewis Hamilton and saying drive my Fiat in a school zone."In today's episode of the Bricks & Bytes, we had Ricky from Deep Space and we got to learn about why most founders hire the wrong sales leadership at the wrong time, how to scale from zero to unicorn status, and the brutal reality of go-to-market in construction tech... and many more!Ricky took simPro from $10M to over $1B valuation as their first CRO. Now he's doing it again with Deep Space while running his own venture fund.Tune in to find out about:✅ The exact revenue stage when you should hire a CRO (hint: it's not when you think)✅ Why construction sales still requires picking up the phone in 2025✅ How to build repeatable sales processes that actually work in AEC✅ The real difference between good and bad revenue leadersListen now on Spotify and learn from someone who's actually built the playbook.Chapters00:00 Intro01:50 Introduction and Guest Background05:48 Ricky's Journey in Tech and Venture Capital09:56 The Role of a Chief Revenue Officer (CRO)13:56 Sales Strategies and Market Adaptation17:51 Building Trust and Value in Sales21:46 Hiring Sales Reps and Team Dynamics25:38 Identifying the Right CRO for Your Business29:49 Metrics for Evaluating a CRO33:55 Advice for Early-Stage Founders36:01 Marketing and Content Strategy in AEC Tech37:54 Navigating Domain Expertise in Marketing41:15 Understanding the Sales Cycle Touchpoints43:49 Essential Tools for Early-Stage Businesses45:51 Deep Space: The Future of Construction Management Software52:52 Transparent Pricing in Software Solutions53:46 The Evolution of Product Management55:50 Balancing AI Adoption with Business Strategy57:52 Analyzing Ricky's LinkedIn Insights

Send us a textIn this laid-back yet deeply insightful conversation recorded live at Pax8 Beyond 2025, Joey Pinz sits down with Charlie Tomeo, CRO of Rewst, to talk automation, community, and catching kingfish.Charlie shares how his love for fishing helps him reset from the startup grind, offering a rare glimpse into the human side of high-stakes leadership. But the conversation quickly dives into strategy as he explains how Rewstempowers MSPs to automate both the obvious (onboarding, offboarding, password resets) and the often-overlooked “high-hanging fruit” — tasks MSPs haven't automated because they've never done them at all.Rewst isn't just saving time — it's transforming automation into a revenue source and making MSPs indispensable to their clients. Charlie explains how their open canvas approach lets both beginners and tech artists build powerful, customized workflows.We also dig into how leadership is evolving, especially for younger tech teams. Charlie discusses mentorship, motivation, and the value of listening — whether on a Rewst open mic call or in the field with a fishing rod. 

Crypto News: Blackrock now holds 700,00 Bitcoin in its ETF. Trump's Truth Social files for index-based crypto ETF which includes XRP, Solana, CRO, Ethereum, and Bitcoin.Show Sponsor -

Today on the Invest In Her podcast, host Catherine Gray talks with Anne Richie, Managing Director and Founder of The Mezzanine Fund. With a distinguished career spanning over two decades, Anne has helped reshape how capital flows to overlooked entrepreneurs by providing flexible debt capital through her fund. She also leads ACR Capital and has extensive experience across the capital spectrum, including roles in distressed lending, private equity, and venture capital. Anne has served as a CFO and CRO, advised more than 100 businesses annually through the Goldman Sachs 10,000 Small Businesses Initiative, and is a respected speaker and educator on capital access. Her impressive resume includes board memberships, awards from Crain's Cleveland, and an MBA from the University of Michigan. In this episode, Anne breaks down the importance of flexible debt and why traditional funding mechanisms often fail to support small and underserved businesses. She shares how The Mezzanine Fund fills this gap by offering non-dilutive capital to help entrepreneurs achieve sustainable growth without giving up equity. Catherine and Anne explore the nuances of debt versus equity, how capital should serve the business owner—not the other way around—and Anne's mission to ensure more women and minority-owned businesses gain fair access to growth capital. Her insights are both inspiring and actionable for founders looking to scale on their own terms. Website Mentioned: https://www.themezzaninefund.com https://www.showherthemoneymovie.com https://svwomenfoundersfund.vc www.sheangelinvestors.com    Follow Us On Social Facebook @sheangelinvestors Twitter (X) @sheangelsinvest Instagram @sheangelinvestors & @catherinegray_investinher LinkedIn @catherinelgray & @sheangels  

Hybrid Marketing Co. Vice President of Strategy, Jenny Lamboy, and Bayou City Hemp Co. and co-founder of Howdy THC beverage CRO, Joel Canada, discuss the recent veto of Texas Senate bill 3 and House bill 28, which could have banned all hemp THC beverages in Texas. Learn what effort went into overcoming these bills, the stakes involved, and what the future holds.

09th July

Truth Social Files for “Crypto Blue Chip ETF”! Trump's Truth Social just filed to launch its very own Crypto Blue Chip ETF — and it's packed with heavy hitters: Bitcoin, Ethereum (ETH), Solana (SOL), XRP, and Cronos (CRO). But here's the twist... CRO will have a bigger allocation than XRP.

Joelle Kaufman has been both a CRO and a CMO—and she's here to tell you: if sales and marketing aren't on the same page, you're leaving revenue on the table.  In this Huddles Quick Take, Joelle outlines the three most common mistakes CMOs make when trying to align with sales—and how to avoid them. From pipeline goals to budget tension to attribution battles, Joelle shares how CMOs can build better partnerships that actually drive revenue.  What You'll Learn:  3 alignment mistakes that keep marketing and sales at odds  Why obsessing over MQLs sends the wrong signal  How shared pipeline goals help unify teams  The real problem with attribution finger-pointing    For the rest of the conversation with Joelle, visit our YouTube channel (CMO Huddles Hub) or click here: https://www.youtube.com/watch?v=64XHb_E7UT4.  Get more insights like these by joining our free Starter program at cmohuddles.com.   For full show notes and transcripts, visit https://renegademarketing.com/podcasts/ To learn more about CMO Huddles, visit https://cmohuddles.com/

Not all consultants are worth it. Some drive real impact. Others just burn your time and budget.In this episode, Toni and Raul dive into how to tell the difference. They break down when it actually makes sense to bring in outside help, how to vet someone properly, and the biggest red flags to avoid.You'll learn why consulting is a real skill, what good execution support looks like, and how to think about pricing and value. (00:00) - Introduction (02:48) - Do you actually need consultants? (05:22) - The consulting relationship with startups (08:29) - Identifying red flags (10:41) - The hammer people (16:17) - Consulting is a skill (21:14) - Consultants as challengers (24:40) - Pricing and value in consulting (30:06) - Execution and enablement (33:38) - Summary (35:45) - Next week: Chris Tottman on VCs

Six leaders from across tech — from SaaS and semis to law and logistics — come together for our 250th episode milestone in this very special AI recap, where we unpack how new advances are transforming the way industries function, and how work gets done.Featuring:• Bret Taylor (Sierra Co-founder)• Winston Weinberg (Harvey Co-founder and CEO)• Matt Murphy (Marvell Technology Chairman and CEO)• Yamini Rangan (HubSpot CEO)• Chris Urmson (Aurora CEO)• Varun Mohan (Windsurf Co-founder and CEO)Connect with Joubin:- LinkedIn: https://www.linkedin.com/in/joubin-mirzadegan-66186854/ - X:  https://x.com/Joubinmir Email: grit@kleinerperkins.comLearn more about Kleiner Perkins: https://www.kleinerperkins.com

In this episode of Make It Happen Mondays, John Barrows sits down with Luke Arno, CRO at Transcend and a powerhouse revenue leader who's scaled growth at companies like Twilio Segment and Box. Luke shares what sets truly great sales teams apart—and why coaching, optimism, and grit are the unteachable qualities every leader should look for.They dive deep into the differences between coaching, mentoring, and leadership, and why enablement is the most overlooked growth lever in business today. Luke explains how to shift enablement from a reactive support function into a proactive, strategic driver—and why sales fundamentals matter now more than ever in an era of AI and automation.From hiring for passion to rebalancing the art and science of sales, this conversation is packed with actionable ideas and fresh perspectives on how to build a team—and a culture—that thrives.If you're wondering where to focus in a world of endless tools and playbooks, this one's for you.Are you interested in leveling up your sales skills and staying relevant in today's AI-driven landscape? Visit www.jbarrows.com and let's Make It Happen together!Connect with John on LinkedIn: https://www.linkedin.com/in/johnbarrows/Connect with John on IG: https://www.instagram.com/johnmbarrows/Check out John's Membership: https://go.jbarrows.com/pages/individual-membership?ref=3edab1 Join John's Newsletter: https://www.jbarrows.com/newsletterConnect with Luke on LinkedIn: luke@transcend.ioCheck out Tanscend's Website: https://transcend.io/Interested in job opportunities? https://transcend.io/careersAlso checkout Luke's advisory services: https://www.gtmsalescoach.com/

Happy 4th of July weekend! Mark Thompson and Cro talk about showing off at auctions, and getting stuck buying something they could never afford. Donor fatigue is a thing.Tim accidentally messed up Mark's life with an unexpected health crisis... All just to grab a bite in the OC...

Happy 4th of July Weekend!!Jay Leno joins Conway... Just wind them up and let them go!Also, Mark Thompson's feelings about tipping... And... THE DON PARDO COMPETITION.Thompson.Cro.Two men enter.One man leaves in glory.

Hey Family Brand, it's Chris and Melissa! Today's episode is inspired by something we've found to be one of the most underrated (but absolutely essential) roles in leadership — whether you're running a company or raising a family: becoming the Chief Reminding Officer. This idea came up during one of our walks, and we realized how much of parenting and leadership isn't about coming up with something brand new every day. It's about consistently reminding your team — or your kids — of what's already true. Who you are. What you stand for. What you value. And honestly? That kind of consistency is powerful. We talk about how we've seen this play out in our own family, especially in real-time with our oldest son, Tate, who's away selling pest control this summer. One day was the worst — he twisted his ankle, was over everything, and needed a pep talk. The next? He crushed it and had his best sales day ever. What changed? Not a brand-new strategy. Just a reminder of something he'd already heard 100 times: don't be attached to the outcome. If you've ever felt tired of repeating yourself or wondering why your spouse or your kids aren't just getting it — you're not alone. But today, we want to encourage you to flip that frustration into purpose. Your job isn't just to lead once. It's to lovingly lead over and over again, through your reminders, your example, and your consistency. We also talk about grace — because hey, God reminds us daily. So maybe it's okay that we have to remind our kids, our spouses, and ourselves. Not in a nagging way, but in a nurturing way. Because that's what creates strong families and real connection: truth repeated in love. Let's normalize being the CRO — Chief Reminding Officer — of our homes. And let's wear that title with pride. LINKS: All Links Family Brand!  stan.store/familybrand Episode Minute By Minute: 0:00 – What it means to be a Chief Reminding Officer (CRO) 1:30 – Why consistent reminders beat constant innovation 3:00 – Family rhythms that work when you stay consistent 4:45 – How inconsistency causes things to fall apart 6:00 – The power of applying what you already know 7:15 – A story about Tate's worst day… and best day the very next day 8:30 – Why reminders can be more powerful than new advice 9:30 – Giving grace to your spouse and kids when they need another reminder 10:15 – Melissa shares how even God reminds us again and again 11:00 – Final encouragement: Go be the best CRO you can be

In this episode of TECHtonic, TSIA's Executive Director and EVP Thomas Lah is joined by Chris Albro and Chad O'Connor, co-CROs at People.ai, for a frank and forward-looking conversation about how artificial intelligence is transforming modern sales organizations. With decades of sales leadership experience at companies such as Oracle, Siebel, and Outreach, Chris and Chad bring grounded, practical insight into what they call the "Four Sales Rituals": coaching, account planning, opportunity management, and forecasting. These essential processes are often still run on outdated, manual routines, leaving revenue teams inefficient and reactive. But AI is upending that status quo. From automating CRM data capture to uncovering hidden deal risks and enhancing forecast accuracy, this episode examines how forward-thinking sales teams are leveraging AI to work smarter—and win more.But this isn't just an efficiency story. It's about reimagining the role of the sales professional in a world where data and AI augment every decision. The guests explain how AI enables more meaningful customer interactions by freeing reps to focus on strategic, human-driven work, and why clinging to “gut instinct” is becoming a liability. Thomas, Chris, and Chad explore the cultural resistance to AI adoption, the leadership mindsets required to overcome it, and the career-defining opportunities salespeople have if they choose to embrace AI now. Whether you're a CRO, RevOps leader, or quota-carrying AE, this episode is a must-listen wake-up call for anyone in tech sales today.

Send us a textWhen people talk about clinical trials, they usually think of drugs, but what about the tools that deliver, diagnose, and detect? Medical device Innovation often flies under the radar despite being essential to modern care. In this episode of the HealthBiz Podcast, Jason Monteleone, CEO of Avania, discusses how his firm helps medtech, diagnostics, and digital health companies navigate clinical trials and regulatory hurdles.

Ever felt like a CEO's life is a roller coaster, with more downs than ups?  That's exactly what Sahil Patel, 2x founder and current CEO of Spiralyze, is here to unpack. In this episode, Sahil dives deep into the gritty reality of entrepreneurship, describing how to live in the valleys and still lead authentically. He unpacks hard-earned lessons from ER Express, explains why small markets can kill growth dreams, and reveals his proven website conversion strategies through A/B testing.  Plus, mental health and therapy for business leaders get a full spotlight. What You'll Learn: Why “living in the valley” is the real CEO mindset nobody talks about How anxiety kills leadership, and calm earns real loyalty The truth behind Sahil's ER Express exit (and why it wasn't a beach-check payday) Why most B2B websites fail the 3-second test, and how to fix it How showing pricing (even for complex products) can boost conversions The CRO mistake nearly every small business makes on their homepage Why therapy might be the smartest investment for founders under pressure Favorite Quote: “You got to learn to live in the valley... that is part of the job. Maybe that even is the job.”   Who is Sahil? Sahil Patel is a two-time founder. He co-founded and led ER Express (a health-tech platform) and now heads Spiralyze, a conversion-rate optimization powerhouse. He's built businesses that tackle real-world problems and writes weekly CRO tips on LinkedIn.   Why Should You Listen? Tune in to rethink how you handle failure, sharpen your website game, and protect your mental well-being.   Connect with Sahil: Website: https://www.spiralyze.com LinkedIn (Personal): https://www.linkedin.com/in/sahilanamipatel  

Frank Sondors is the Founder and CRO of SalesForge. Frank and his team have an AI powered Outreach solution that has had some of the fastest growth I've ever seen. But this isn't about the tired approach to revenue growth you are already familiar with. This is a blueprint for record setting performance with minimum headcount required. Frank and his team today service over 2,000 customers and are growing at an incredible clip by raising capital through sales…not investment. He's living proof that you can have remarkable growth by servicing customers…not investors. Today he shares a blueprint of sales success built on lean teams, automated operations, and new innovations to your GTM rhythm that results in a finely-tuned engine. As you enter the 2nd half of 2025…this is a perfectly-timed conversation that will help you think different as a leader. You can connect with Frank on LinkedIn here. (https://www.linkedin.com/in/franksondors/) You can check out SalesForge here. (https://www.salesforge.ai/) You can check out Agent Frank here. (https://www.salesforge.ai/agent/frank#af-ai-email) For video excerpts of this and other episodes of the Sales Leadership Podcast, check out Sales Leadership United Here. (https://www.patreon.com/c/SalesLeadershipUnited)

In this episode of Let's Combinate, Archana shares her insights on the critical factors involved in designing clinical trials, from phase one safety profiling to pivotal phase three trials. She also discusses the importance of patient diversity, the ethical considerations in clinical research, and the future of clinical trials, including decentralized trials and the use of advanced technologies. The conversation highlights the intricate balance between maintaining rigorous scientific standards and adapting to new methodologies to enhance patient recruitment and data integrity. Time Stamps: 00:00 Welcome and Introduction 00:28 Understanding Clinical Trial Design 00:58 Phases of Clinical Trials 02:27 Oncology Trials and Patient Pathways 05:00 Protocol Design and Regulatory Considerations 08:40 Patient Preferences and Vendor Selection 18:53 Types of Clinical Trials 23:01 Understanding BA and BE Studies 24:39 Clinical Coordination of BA/BE Studies 25:15 Infrastructure and Emergency Management in Clinical Trials 26:19 Addressing Mistrust in Clinical Trials 29:54 Ensuring Diversity in Clinical Trials 32:41 The Rise of Decentralized Clinical Trials 39:06 Challenges and Solutions in Decentralized Trials 42:49 Technology and Regulation in Clinical Trials 47:28 Final Thoughts and Contact InformationArchana Sah is a Clinical development thought leader with extensive (30 years) experience and passion for developing medicines for patients having led and contributed to 15 FDA/EMEA drug approvals including Tecentriq® in multiple indications and combinations, Alecensa®, Polivy®, Hemlibra®, Gazyva®, Pixuvri®. She has held various global positions within Biotech, Big pharma, CRO including Genentech/Roche, Bayer Oncology, Johnson & Johnson, ICON, and two Oncology biotech start up companies. She has also worked in healthcare technology as the Senior Vice President of Digital and Decentralized Solutions at Medable Inc. She is now an independent strategy consultant and Board Advisor and provides strategic advisory services to pharma, biotechs, digital healthtech software companies, venture firms in clinical development and operations as well as on leveraging innovative patient centered digital health technologies in a fit for purpose approach to improve diversity, access and efficiencies within the healthcare ecosystem. She has been honored as Top20 women in immuno oncology drug development and featured in PharmaFEATURES on Oncology drug development and Digital Health technology.She has routinely led several industry collaboration consortiums. She is the co-founding chair and member of Society for Clinical Research Sites Oncology Board and chaired the Annual Oncology Summits. She is a current Mentor for the CancerX Moonshot program dedicated to revolutionizing advancements in cancer care, clinical trials, patient support, biotech & pharma and drive integration of digital tools in oncology. She serves on the Leadership Council for Decentralized Trials and Research Alliance(DTRA) and as their Evidence/Publications Librarian. She also serves as an Advisor to American Cancer Society Cancer Action Network (ACS CAN) and is a reviewer for the international Journal of the American Cancer Society "Cancer". Invited advisor and keynote/speaker at several industry conferences.Contact: archana.sah@aspharmaadvisors.comSubhi Saadeh is a Quality Professional and host of Let's Combinate. With a background in Quality, Manufacturing Operations, and R&D, he has worked in large Medical Device and Pharma organizations to support the development and launch of hardware devices, disposable devices, and combination products for vaccines, generics, and biologics.Subhi currently serves as the International Committee Chair for the Combination Products Coalition (CPC), is a member of ASTM Committee E55, and has served on AAMI's Combination Products Committee.

In this weeks' Scale Your Sales Podcast episode, my guest is Nick Buxton.   Nick has a background in engineering, 2x CRO, and 5x VP of Sales. Over the past 20 years I've worked my way up from individual contributor at seed, Series A- C, privately held, FTSE and NYSE listed tech companies. He is now helping tech companies deliver revenue transformation projects with a range of partners.   In today's episode of Scale Your Sales podcast, Nick shares his value-led growth approach and why breaking down silos between sales, marketing, and customer success is key to building customer-centric organizations. He and Janice explore the difference between solving user problems vs. business needs, the impact on go-to-market strategy, and the evolving role of CROs as AI and sales enablement continue to reshape the future of sales.   Welcome to Scale Your Sales Podcast, Nick Buxton.     Timestamps: 00:00 Product-Led Growth Challenges Explained 05:51 Embrace Product-Led Growth Strategy 07:09 Customer-Led Growth Insights 13:29 Sales Competency Deficit Analysis 14:41 Challenges in Building Sales Relationships 20:13 Improving Sales Leadership Competencies 22:08 Sales Enablement and CROs Alignment 25:20 Understanding Product Value Basics 28:31 Silent Quitting: Mutual Interview Necessity     https://www.linkedin.com/in/nick-buxton/     Janice B Gordon is the award-winning Customer Growth Expert and Scale Your Sales Framework founder. She is by LinkedIn Sales 15 Innovating Sales Influencers to Follow 2021, the Top 50 Global Thought Leaders and Influencers on Customer Experience Nov 2020 and 150 Women B2B Thought Leaders You Should Follow in 2021. Janice helps companies worldwide to reimagine revenue growth thought customer experience and sales.   Book Janice to speak virtually at your next event: https://janicebgordon.com LinkedIn: https://www.linkedin.com/janice-b-gordon/ Twitter: https://twitter.com/JaniceBGordon Scale Your Sales Podcast: https://scaleyoursales.co.uk/podcast More on the blog: https://scaleyoursales.co.uk/blog Instagram: https://www.instagram.com/janicebgordon Facebook: https://www.facebook.com/ScaleYourSales And more!   Visit our podcast website https://scaleyoursales.co.uk/podcast/ to watch or listen.

In this episode of The Modern Hotelier, we're live from the iconic Dallara IndyCar Factory in Indianapolis, joined by Tristan Gadsby, CEO of Alliants, and Alberto Santana, CRO of Alliants.Together, we explore how hospitality is shifting gears from clunky, fragmented tech to seamless, guest-first experiences. From reinventing contactless solutions post-COVID to ditching plastic key cards in favor of NFC technology, Alliants is helping hotels rediscover what true hospitality feels like—personal, powerful, and friction-free.Learn how:Resorts World Las Vegas revamped their tech stack for an end-to-end contactless experience.NFC keys are revolutionizing guest access (and finally working in elevators).Hotels can personalize stays before the guest even arrives—boosting revenue and delight.The outdated idea of “reception” is being replaced with something much more human.And don't miss Alberto's fiery take on why hospitality needs to break up with transactions and start having real conversations.Whether you're a tech-savvy GM or just curious about the future of hotel experiences, this is the episode that connects the dots between innovation and true hospitality.Watch the FULL EPISODE on YouTube: https://youtu.be/NWvNNOdcMbIThis episode is sponsored by Alliants: https://www.alliants.com/Join the conversation on today's episode on The Modern Hotelier LinkedIn pageThe Modern Hotelier is produced, edited, and published by Make More MediaLinks:Tristan GadsbyTristan on LinkedIn: https://www.linkedin.com/in/tristangadsby/Alliants: https://www.alliants.com/ Alberto SantanaAlberto on LinkedIn: https://www.linkedin.com/in/mrsantana/For full show notes head to: https://themodernhotelier.com/episode/177Follow on LinkedIn: https://www.linkedin.com/company/the-...Connect with Steve and David:Steve: https://www.linkedin.com/in/%F0%9F%8E...David: https://www.linkedin.com/in/david-mil.

In a world of AI-generated noise and automated outreach, Cliff Simon has built a multi-million dollar business by doing something simple but rare: showing up in person.In this episode, Cliff shares how he turned events, community dinners, and authentic relationships into a powerful go-to-market strategy. He breaks down why most event-based approaches fail, what it really means to play the long game, and how founders and revenue leaders can drive growth without relying on cold outreach.Never miss a new episode! Join our newsletter at revenueformula.substack.com(00:00) - Introduction (01:53) - The Importance of In-Person (06:01) - The Role of Pavilion (08:08) - Building Relationships (12:09) - Building for Long Term (16:41) - Modern Networking Tactics (21:58) - Evaluating Event Success (24:57) - Common Misconceptions in Event Strategy (26:34) - Effective Event Strategies (31:39) - The Power of Personal Branding (32:13) - Comparing Rev Ops Events (36:28) - Next Week: What You Need to Know About Consultants  

If your big deals are stalling, John McMahon says it likely comes down to one mistake: confusing a coach with a champion.We're re-releasing one of our most popular episodes ever with the legendary John McMahon, former CRO at iconic companies like PTC and Ariba and author of The Qualified Sales Leader. He joins Ross to deliver some famously direct truths about what it really takes to win.This isn't about complex theories. It's about getting the fundamentals right. Here are three things you'll learn from John in this episode:The Coach vs. Champion Test: A coach gives you information, but a champion has influence and gets you to the economic buyer. Learn John's simple test to find out which one you really have.Make Fundamentals Muscle Memory: Reps can't listen if they're busy trying to remember the playbook. John explains how to turn your process into an instinct, freeing up reps to actually focus on navigating the deal.How to Compete Against Everyone: You're no longer just competing against other vendors. You're up against every other investment the CFO is reviewing. Learn how to ensure your champion is ready to fight for your business case.

What happens when a founder-led sales strategy hits its limits? In this episode of Coach to Scale, Ken Grasso, veteran CRO, advisor, and founder of Catalyst Peak Ventures, pulls back the curtain on the messy, mission-critical transition from instinct-driven selling to structured, scalable revenue operations. With experience leading global go-to-market teams and helping companies grow from zero to IPO, Ken shares unfiltered insights on why founders often struggle to let go of sales, the costly myth of the “natural-born” sales leader, and how process, not personality, is the real growth engine.Packed with real talk for CROs, revenue leaders, and founders alike, this conversation explores the pivotal role of coaching cultures, how to hire for system-fit over resume flash, and the urgent need to professionalize sales before seeking investment or exit. You'll also hear Ken's candid reflections on career reinvention, building credibility as a fractional exec, and why planning for the next chapter before you need to is essential for long-term impact. Whether you're scaling your first team or rethinking what makes sales truly sustainable, this episode is a playbook in disguise.Top Takeaways1. Founder-led selling becomes a liability as you scaleEarly-stage founders may be the best sellers at first, but their instinctive, unstructured style can block repeatability and growth.2. Great sales reps don't automatically make great managersPromoting top performers without leadership skills or process discipline can stall team performance and create chaos.3. The sales process is the foundation, not a nice-to-haveA defined, teachable sales process enables forecastable growth, efficient onboarding, and higher valuations.4. CROs must earn trust and re-educate founders on go-to-marketTransitioning founder-led orgs to scalable operations requires a blend of credibility, patience, and strategic coaching.5. Hiring should prioritize system-fit and coachability.The best candidates align with your GTM model and are eager to operate within a defined system, not just shine as individual contributors.6. You can't outrun a broken foundation with short-term winsHeroics might save a quarter, but without an operational structure, you'll eventually burn out or break the model.7. Fractional leadership can unlock massive value for growth-stage teamsBringing in experienced operators part-time can help companies avoid costly misfires and build maturity without overextending budgets.8. Plan your career pivot before the market makes you do itKen urges seasoned leaders to proactively define their “Plan B,” emphasizing personal reinvention and long-term career resilience.9. Strong systems beat star power—ask the NFL.Drawing on sports analogies, Ken explains why team performance relies more on consistent playbooks than flashy individuals.10. Valuation depends on your GTM maturity.Investors and acquirers don't just buy your product they buy your ability to sell it repeatedly, predictably, and without founder involvement

Daragh Murphy is giving brands their own credit-card platform—no legacy bank required.On this week's Grit, the Imprint co-founder and CEO traces the leap from being a junior lawyer to closing nine-figure card deals.He breaks down the hidden economics of credit-card loyalty, the discipline of treating capital “like the last dollar,” and how AI will slash risk-and-support costs.Guest: Daragh Murphy, CEO & Co-Founder of ImprintChapters:00:00 Trailer00:48 Introduction01:30 Actualizing the dream08:37 Imprint11:37 Partnerships are massive16:48 Understand the market18:42 “Get more, spend more” tradeoffs23:57 Fishing in the wrong ponds31:32 Can't skip work32:43 Exciting and scary34:56 Pride and ownership46:50 The way you spend your day50:20 New technologies54:51 Who Imprint is hiring54:59 What “grit” means to Daragh55:34 OutroMentioned in this episode: Figma, Rippling, H-E-B Grocery Company, LP, Barclays US, IBM, Coinbase, Charlie Munger, Instagram, Hamptons, Google, Nick Huber, Ribbit, Ireland, WeWork, Adam Kim, Amazon, Shopify, Tobias Lütke, Duolingo, Parker ConradLinks:Connect with DaraghLinkedInConnect with JoubinXLinkedInEmail: grit@kleinerperkins.comLearn more about Kleiner Perkins

In this short segment of the Revenue Builders Podcast, we revisit the discussion with George Mogannam, CRO of Celigo, to explore the foundational gaps that hinder scalable growth—particularly in recruiting, onboarding, and team cohesion. George unpacks what most companies miss when trying to scale, including the absence of ideal hiring profiles, lack of onboarding discipline, and broken internal processes. He also emphasizes the power of in-person connection, the hidden cost of remote culture, and the importance of aligning internal teams during growth surges.KEY TAKEAWAYS[00:00:25] Common Gaps in Scaling Sales Teams: Many organizations lack ideal hiring profiles, onboarding processes, KPIs, and operational rhythms.[00:01:40] Remote Work's Cultural Void: Remote work has eroded the informal peer-to-peer learning and camaraderie critical to high-performing sales teams.[00:02:37] Why In-Person Teams Outperform: George shares research that shows 4x higher churn in remote teams versus co-located ones—highlighting the need for centralized sales orgs.[00:03:37] The True ROI of Sales Kickoffs: More than training, it's the peer interaction, story-sharing, and cross-learning that drive culture and performance.[00:04:30] The Overlooked Bottleneck in Scaling: Many CROs underestimate internal readiness for hiring sprees, especially around slow offer letter processes and internal misalignment.[00:06:59] Fixing Internal Bottlenecks: George details how his team automated contract counter-signatures to reduce booking delays and avoid customer disruptions.QUOTES[00:01:14] “There's a sales process, but no one's really utilizing it… there's no discipline around it.”[00:02:01] “You will get four times higher churn when everybody's remote versus when people are together.”[00:03:37] “The priceless part comes from them all engaging together... more powerful than all the formal training.”[00:04:59] “Companies don't realize they're a walking audition for what it's going to be like to work for them.”[00:06:41] “That's how you burn cash in an organization—when internal readiness doesn't match external hiring urgency.”[00:07:27] “If the order isn't executed at the proper time, we can accidentally shut the customer off.”Listen to the full conversation through the link below.https://revenue-builders.simplecast.com/episodes/scaling-high-growth-sales-organizations-with-george-mogannamEnjoying the podcast? Sign up to receive new episodes straight to your inbox:https://hubs.li/Q02R10xN0Check out John McMahon's book here:Amazon Link: https://a.co/d/1K7DDC4Check out Force Management's Ascender platform here: https://my.ascender.co/Ascender/

In this episode of Molecule to Market, you'll go inside the outsourcing space of the global drug development sector with Gemma Budd, General Manager at Nanopharm. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Gemma, covering: Why being in an overlay strategic, future-focused role led her to make the tough decision to move on Identifying the joy of solving problems for customers in service-based businesses Why her holistic experience led to the GM role...and the reality in becoming the leader The factors driving growth for inhalation delivery for nasal and pulmonary routes Being a niche player in a global market - why clients don't care where you are when you know what you're doing With a background in biomedical science, Gemma has built her career over the past 15 years by leveraging and expanding that knowledge in the pharmaceutical and medical devices industry. She has worked in companies providing analytical and formulation development services, materials science consultancy and manufacturing of drug delivery systems – primarily in commercial and technical roles.  She is currently the General Manager of Nanopharm, a specialist CRO focusing on developing nasally administered and inhaled drug products for pharmaceutical companies worldwide, through her team of 75 employees in the UK. She is focused on ensuring the business continually delivers, innovates and evolves in their niche space to ensure their clients benefit from their expertise that is not widely available in the industry, developing both exceptional talent and unique technology platforms, and ensuring they combine to deliver high quality services to help get drugs to patients quickly, safely and effectively. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We'd also appreciate a positive rating!  Molecule to Market is also sponsored and funded by ramarketing, an international marketing, design, digital and content agency helping companies differentiate, get noticed and grow in life sciences.

Jeremy Horowitz is the Managing Partner of Because Ventures and the creator of Let's Buy a Biz!, a media brand and private equity-backed content engine built to make ecommerce M&A more transparent, data-driven, and founder-friendly. Because Ventures is a private equity search fund focused on acquiring and scaling Shopify brands and apps, while Let's Buy a Biz! documents what it actually takes to grow Top 1% ecommerce businesses.Before launching either venture, Jeremy worked across every layer of the Shopify ecosystem from scaling high-growth DTC brands like Lumi, to leading growth at top-performing Shopify apps like Gorgias. His on-the-ground experience gave him a front-row seat to what really drives retention, profit, and valuation. Now, through Because Ventures, Jeremy applies that knowledge to acquire and operate ecommerce businesses with sustainable margins and focused stacks.Whether debunking the myth that “every brand needs subscriptions,” tracking the 84% adoption rate of email/SMS across $1M+ stores, or predicting which app categories will consolidate over the next five years, Jeremy brings a deep analytical lens to ecommerce strategy. He shares insights from crawling 103,000 Shopify stores, explains why most loyalty programs fail, and urges founders to simplify their tech stack before adding complexity. His story is a masterclass in using real data, not hype to guide business decisions.In This Conversation We Discuss: [00:40] Intro[00:55] Scaling DTC brands to eight figures[02:03] Expanding beyond Shopify Plus assumptions[04:18] Filtering out inactive and duplicate stores[05:05] Highlighting the top 10 most used apps[09:08] Focusing on what actually drives growth[10:56] Comparing native vs third-party app adoption[12:23] Spotting analytics as a breakout category[14:11] Explaining why real CRO starts at $5M+[16:49] Spotting support as an underused category[18:29] Unpacking the subscription model myth[22:47] Auditing app stacks to save thousandsResources:Subscribe to Honest Ecommerce on YoutubeEcommerce Social Impact Fund because.ventures/index.htmlInsider analysis of the largest Ecommerce brands' financials letsbuyabiz.xyz/Follow Jeremy Horowitz linkedin.com/in/jeremyhorowitz1If you're enjoying the show, we'd love it if you left Honest Ecommerce a review on Apple Podcasts. It makes a huge impact on the success of the podcast, and we love reading every one of your reviews!